Malignant mesothelioma with a pronounced myxoid stroma: A clinical and pathological evaluation of 19 cases

Virchows Archiv

Volumn 447, Issue 5, 2005, Pages 828-834

  Shia, Jinru ^a   Qin, Jing ^b   Erlandson, Robert A ^a   King, Roy ^c   Illei, Peter ^d   Nobrega, Jennifer ^a   Yao, Davis ^a   Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Dermatology Associates of Knoxville   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Electron microscopy; Epithelioid mesothelioma; Immunohistochemistry; Myxoid mesothelioma; Survival

Indexed keywords

ALCIAN BLUE; ANTINEOPLASTIC AGENT; ASBESTOS; HYALURONIC ACID; HYALURONIDASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LUNG RESECTION; MALE; MALIGNANT MESOTHELIOMA; MICROVILLUS; PATHOLOGY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; STROMA; SURVIVAL RATE; TUMOR CELL; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MESOTHELIOMA; MIDDLE AGED; MUCUS; NEOPLASM STAGING; PLEURAL NEOPLASMS; STROMAL CELLS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 28444482421     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0035-y     Document Type: Article

References (21)

1. Baas P (2003) Predictive and prognostic factors in malignant pleural mesothelioma. Curr Opin Oncol 15:127-130
2. Butchart EG (1999) Contemporary management of malignant pleural mesothelioma. Oncologist 4:488-500
3. Butchart EG, Ashcroft T, Barnsley WC, Holden MP (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15-24
4. Cook DS, Attanoos RL, Jalloh SS, Gibbs AR (2000) "Mucin- positive" epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall. Histopathology 37:33-36
5. Diaz LK, Okonkwo A, Solans EP, Bedrossian C, Rao MS (2002) Extensive myxoid change in well-differentiated papillary mesothelioma of the pelvic peritoneum. Ann Diagn Pathol 6:164-167
6. Goetz SP, Robinson RA, Landas SK (1992) Extraskeletal myxoid chondrosarcoma of the pleura. Report of a case clinically simulating mesothelioma. Am J Clin Pathol 97:498-502
7. Hammar SP, Bockus DE, Remington FL, Rohrbach KA (1996) Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas. Ultrastruct Pathol 20:293-325
8. Johansson L, Linden CJ (1996) Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 109:109-114
9. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
10. Leonardo E, Zanconati F, Bonifacio D, Bonito LD (2001) Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesothelioma. Pathol Res Pract 197:253-256
11. MacDougall DB, Wang SE, Zidar BL (1992) Mucin-positive epithelial mesothelioma. Arch Pathol Lab Med 116:874-880
12. Marcus PB (1981) Glycocalyceal bodies and their role in tumor typing. J Submicrosc Cytol 13:483-500
13. Mark EJ, Shin DH (1993) Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch, A Pathol Anat Histopathol 422:445-451
14. Robb JA (1989) Mesothelioma versus adenocarcinoma: false-positive CEA and Leu-M1 staining due to hyaluronic acid. Hum Pathol 20:400
15. Rusch VW (1996) A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14:1-12
16. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS, Downey RJ, Ginsberg RJ (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788-795
17. Rusch VW, Venkatraman E (1996) The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 111:815-825 (discussion 825-826)
18. Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68:1799-1804
19. Shia J, Erlandson RA, Klimstra DS (2002) Deciduoid mesothelioma: a report of 5 cases and literature review. Ultrastruct Pathol 26:355-363
20. Yao DX, Shia J, Erlandson RA, Klimstra DS (2004) Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review. Ultrastruct Pathol 28:213-228
21. Yates DH, Corrin B, Stidolph PN, Browne K (1997) Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 52:507-512